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ABSTRACT: Four patients with myelodysplastic syndrome (MDS), one with t(1;7) and three with trisomy 
8, were studied by immunophenotyping and fluorescence in situ hybridization (FISH) to assess cell lin- 
eage involvement. The t(1;7) was detected using a biotin-labeled chromosome I centromere-specific DNA 
probe. This aberration was present in CD34-positive stem cells, the erythroid cell lineage (GPA +), and 
the granulocytic/monocytic (CD13 + and CD64 +) cell lineages. We were not able to demonstrate he ab- 
normality in the lymphoid cell lineages. In the patients with trisomy 8, the aberration was detected with 
chromosome 8 centromere-specific DNA probe or by chromosome in situ suppression hybridization (CISS) 
with a chromosome &specific library probe. The trisomy was detected in stem cells, erythroid precursor 
cells, megakaryocytes, and granulocytes/monocytes. In these MDS patients, the chromosome aberrations 
appear to occur only in cells of myeloid lineage. 
INTRODUCTION 
Myelodysplastic syndrome (MDS) comprises a group of 
clonal stem cell disorders characterized bydysplastic changes 
in bone marrow (BM) morphology. In MDS, BM dysfunction 
usually leads to some degree of anemia, leukopenia, and/or 
thrombocytopenia. A clonal population of neoplastic stem 
cells in the hematopoietic l neage may progress to leukemic 
proliferation: 20-40% of patients will develop acute myelo- 
blastic leukemia (AML) [1]. 
Nonrandom chromosome aberrations are observed in 
more than 50% of MDS patients; some of these cytogenetic 
abnormalities are also frequently observed in AML. The 
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karyotypic features are useful as both prognostic and diag- 
nostic indicators [2]. An unbalanced translocation between 
chromosomes I and 7, t(1;7)(q10;p10), often associated with 
therapy-related MDS, leads to trisomy of the long arm of chro- 
mosome 1and monosomy of the long arm of chromosome 
7. The patients often progress to AML [3-5]. Trisomy 8 ( + 8), 
one of the most frequently occurring chromosome abnormal- 
ities in MDS, also is often observed in AML patients [6]. These 
chromosome aberrations serve as genetic markers for iden- 
tification of neoplastic ells. 
DNA in situ hybridization (ISH) with chromosome-spe- 
cific probes detects the abnormalities in both metaphases and 
interphase nuclei. Combining ISH with immunophenotypic 
classification ofcells, allows the neoplastic clones to be iden- 
tified and assigned to a specific hematopoietic cell lineage 
[7]. This information isvaluable for understanding of the dif- 
ferentiation pathways of hematopoietic cells. Investigation 
of the cell lineage involvement of chromosome aberrations 
in preleukemias may lead to better understanding of the pro- 
cess of leukemogenesis. 
We report four patients with MDS, of whom one had t(1;7) 
and three who had trisomy 8. By combining immunopheno- 
typic analysis with fluorescence ISH (FISH} using centre- 
mere-specific DNA probes or a chromosome library probe, 
we analyzed clonal characteristics of different hematopoi- 
etic neoplastic ell lineages in MDS. 
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MATERIALS AND METHODS 
Patients 
We studied four patients with MDS, three females and one 
male (Table 1). The diagnosis of MDS was made according 
to the criteria of the French-American-British (FAB) Cooper- 
ative Study Group [8]. 
Cytogenetic Studies 
BM aspirates were obtained from all patients; peripheral 
blood (PB) samples were also obtained from patients 1-3. 
Karyotype analysis was performed on unstimulated 24-hour 
BM cell cultures and on phytohemagglutinin (PHA, 0.5 
~g/ml) (Difco Laboratories, Detroit, MI) stimulated PB cul- 
tures. RPMI 1640 medium was supplemented with fetal calf 
serum (20%) L-glutamine (0.29 mg/ml), penicillin (100 U/ml), 
and streptomycin (100 ~g/ml) (all GIBCO, Grand Island, NY). 
Cell cultures were incubated at 37°C in 5% CO2. Harvesting, 
slide preparation, and G-banding were performed by stan- 
dard techniques. At least 15 metaphases per patient sample 
were analyzed. 
Immunophenotyping 
Mononuclear cells from PB and BM cells were isolated by 
one-step density gradient centrifugation in Ficoll-Paque 
(Pharmacia Fine Chemicals, Uppsala, Sweden) and cultured 
for 1-3 days. Cytospin preparations were made as described 
earlier [9]. The immunological phenotype of the cells was 
characterized with a modified alkaline phosphatase-antialka- 
line phosphatase method (APAAP) [10] with the following 
monoclonal antibodies. Anti-CD34 (My10) (Becton Dickin- 
son, San Jose, CA) recognizes hematopoietic pre ursor cells; 
anti-CD13 (My7) (Coulter, Hialeah, FL) recognizes the granu- 
locytic and monocytic lineages, and antiglycophorin A (anti- 
GPA; provided by Dr. Griffin, Boston, MA) is specific for the 
erythroid cell lineage. Anti-CD61 (Y-2/51) (provided by Dr. 
Mason, Oxford, England) recognizes platelets/megakaryo- 
cytes. Anti-CD3 (Leu4) (Becton Dickinson, Erembodegem, 
Belgium) identifies T cells, and a mixture of anti-CD2O and 
anti-CD22 (Coulter and Janssen Biochimica, Beerse, Belgium) 
identifies B cells. Anti-CD64 (Serotec, Oxford, England) is 
a monocyte-specific antibody; anti-CD56 (Leu 19) and anti- 
CD16 (Leulla, b, and c) (Becton Dickinson) are specific for 
large granular lymphocytes (lJgL). After immunophenotyp- 
ing was completed, the cells were counterstained with 
Giemsa. The positive mitotic and interphase cells were scored 
and photographed on Kodak Ektachrome EPY-64T film. 
FISH 
For FISH, Giemsa stain and APAAP were dissolved in meth- 
anol:acetic acid (3:1) for at least I hour and the samples were 
air-dried. The cytoplasm was removed from the cells by treat- 
ment with pepsin (0.1 mg/ml in 0.01 N HC1) for 6 minutes 
at 37°C. The slides were rinsed in distilled water and de- 
hydrated in an ethanol series. All hybridizations were per- 
formed within 4 weeks of APAAP staining. 
DNA Probes and Nonradioactive Labeling. For FISH of chro- 
mosome 1, we used a repeat-sequence satellite DNA probe 
for the heterochromatin region at lq12 (pUC1.77) [11]. Cells 
with the t(1;7) show three signals per nucleus, two from nor- 
mal chromosome 1 and one from the translocation deriva- 
tive. For detection of chromosome 8 trisomy, we used a 
centromere-specific a-satellite DNA probe generated by poly- 
Table 1 Immunophenotyping and FISH on samples from MDS patients 
Patient/age Probe # Frequency of Total no. 
(yr)/sex Diagnosis Cell lineage M/I abnormal cells of cells G-banding karyotype 
1/58/F MDS, RA Interphase cells 1// 28 200 46,XX, + der(1;7) 
(ql0;pl0), - 717]/46,XX[9] 
2/65/F MDS, RAEB 
3/48/F MDS, RA 
4/64/M MDS, RA 
Stem cell (CD34) 1// 35 65 
Granulocytic/monocytic (CD13) 1// 20 34 
Monocytic (CD64) 1// 50 52 
Erythrocytic (GPA) 1/M 78 15 
1// 40 50 
T-lymphocytic (CD3) 1// 1.7 300 
B-lymphocytic (CD20 and CD22) 1// 2.5 250 
LGL ceils (CD56) 1// 1.6 62 
LGL ceils (CD16) 1// 1.6 61 
Metaphase cells 8 (CISS)/M 5 54 
Stem cell (CD34) 8 (CISS)/M 5 20 
Erythrocytic (GPA) 8 (CISS)/M 5.5 70 
Granulocytic/monocytic (CD13) 8 (CISS)/M 0.66 150 
Metaphase cells 8 (CISS)/M 1 246 
Metaphase cells (after BMT) 8 (CISS)/M 0 900 
Interphase cells 8/I 9 130 
Metaphase ceils 8 (CISS)/M 18 380 
Erythrocytic (GPA) 8// 8 110 
Megakaryocytic 8// 10 45 
Monocytic (CD64) 8 (CISS)/M 15 200 
47,XX, + 815]/46,XX[15] 
47,XX, + 816]/46,XX[192] 
47,XY, + 8112]/46,XY[33] 
Abbreviations: FISH, fluorescence in s tu hybridization; MDS, myelodysplastic syndrome; RA, refractory anemia; RAEB, RA with excess of blasts; M, 
metaphase c lls; I, interphase cells; CISS, chromosome in situ suppression hybridization. 
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Figure 1 Bone marrow (BM) cells from patient 1 showing (A) glycophorin A (GPA)-positive cell of the erythroid 
lineage (arrow). (B) Same cells after fluorescence in situ hybridization (FISH) with a chromosome 1-specific repeat- 
sequence DNA probe. Arrows show signals of the hybridized probe on chromosome 1 and der(1;7)(ql0; pl0). (C) BM 
cells from the same patient showing CD64-positive monocytes. (D) Same cells after FISH with the probe for chromo- 
some 1. Arrows show one of the positive cells and signals in the interphase nucleus. 
merase chain reaction (PCR) with oligonucleotide primers 
for conserved regions of the a-satellite monomer [12]. The 
source of DNA amplification was a chromosome 8 plasmid 
library probe (Library LL08NS02, American Type Culture 
Collection, ATCC). Chromosome in situ suppression hybrid- 
ization (CISS) of chromosome 8 metaphase cells was per- 
formed with the library probe described above. Ceils with 
trisomy 8 show three signals with these probes. 
The chromosome I centromere-specific probe (#1) and the 
chromosome 8 library probe were labeled by nick-translation 
using biotin-11-dUTP (Sigma, St. Louis, MO) and a nick- 
translation kit (Nick Translation Kit, Bethesda Research 
Laboratories, Bethesda, MD) in the manner ecommended 
by the manufacturer. The centromere-specific probe f r chro- 
mosome 8 (#8) was labeled with digoxigenin41-dUTP (Boeh- 
ringer Mannheim GmbH, Mannheim, Germany) during PCR. 
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We performed FISH as described by Pinkel et al., with 
modifications [13]. After labeling, the biotinylated probe #1 
was dissolved in a hybridization mixture containing 60% 
deionized formamide (Gibco BRL, Gaithersburg, MD), 10% 
dextran sulfate (Sigma), 2 x SSC and 0.5 mg/ml herring sperm 
DNA (Sigma). The hybridization mixture for #8 contained 
65% formamide in 2 x SSC. We performed CISS as described 
elsewhere [14, 15]. 
Slides hybridized with probe #1 were washed three times 
in 60% formamide, 2 x SSC (pH 7.0) and Tween 0.05% at 44°C 
for 5 minutes each, followed by three 5-minute washes in 
0.1x SSC at room temperature. Slides hybridized with #8 were 
washed in three changes of 50% formamide, 2 x SSC (pH 7.0) 
at 45°C for 5 minutes each and finally three times in 0.1× SSC 
for 5 minutes each. Slides hybridized with the chromosome 
8 library probe were washed three times in 50% formamide 
for 5 minutes each, and again three times for 5 minutes in 
0.1x SSC at 58°C. 
Probe Detection 
After being washed, the slides were incubated in bovine se- 
rum albumin (Boehringer Mannheim) at 37°C for 30 minutes. 
The biotinylated probe #1 was detected using avidin con- 
jugated with FITC (1:200, Vector Laboratories, Burlingame, 
CA) followed by biotinylated goat antiavidin (1:200, Vector) 
and avidin-FITC, as described by Pinkel et al. [13]. For detec- 
tion of #8, we used a sequential layer with mouse anti-digoxi- 
genin (1:500), FITC-conjugated sheep anti-mouse antibody 
(1:200), and FITC-conjugated onkey anti-sheep antibody 
(1:200) (all Sigma) [16]. Cells were counterstained with 
propidium iodide (0.001 mg/ml, Sigma) and 4', 6-diamidino- 
2-phenylindole dihydrochloride (DAPI) (5 mg/ml, Sigma), 
and mounted in fluorescence antifading buffer [17]. 
Microscopic evaluation was made with a Leitz Laborlux 
D fluorescence photomicroscope equipped with filter sets 
Leitz I2/3 (FITC) and A (DAPI). Analysis of metaphase c lls 
and interphase nuclei was made by two observers according 
to the criteria described by Hopman et al. [18]. Photographs 
were taken on Kodak Ektachrome 400 ASA color slide film. 
RESULTS 
Immunophenotyping combined with DNA FISH was per- 
formed on BM specimens and PB cells from patients 1and 
2 and on BM from patient 4. FISH without immunophenotyp- 
ing was performed on BM from patient 3. Results are shown 
in Table 1. 
Patient 1 had t(1;7) as the only cytogenetic abnormality. 
With FISH, the translocation was detected in the CD34- 
positive stem cells and in the CD13-positive granulocytic/ 
monocytic ell lineage. CD64 + monocytes had the abnor- 
mality (Fig. 1C and D). The translocation was further shown 
in the GPA-positive rythroid lineage (Fig. 1A and B). CD61- 
positive megakaryocyte metaphase cells yielded three sig- 
nals (frequencies not estimated). The frequency of T- and 
B-cells showing three signals was 1.7% and 2.5%, respectively; 
1.6 % of the CD56-positive LGL-cells (NK cells and T-cell sub- 
set) and 1.6% of the CD16-positive LGL-cells yielded three 
signals. 
Patient 2 had trisomy 8 in about 5% of metaphases stud- 
ied by CISS. The trisomy was evident in the CD34-positive 
stem cells and in the erythroid lineage. The CD13 + granulo- 
cytic/monocytic l neage did not contain the aberration. The 
lymphocytic lineage was not studied. 
Patient 3 showed trisomy 8 in only about 1% of metaphases 
at diagnosis, as analyzed by CISS with the chromosome 8 
library probe. Because of the low frequency of trisomic ells, 
cell lineage specificity could not be studied. After BM trans- 
plantation, no trisomy was observed by FISH or CISS. 
Trisomy 8 in patient 4was studied with the chromosome 
8 repeat-sequence probe in BM interphase cells; 9% of all 
cells showed three signals. Chromosome painting of meta- 
phases using the library probe showed the trisomy in 18%. 
After immunophenotyping, cells of the GPA-positive ryth- 
roid lineage and CD61-positive megakaryocytic cells were 
shown to be trisomic. The CD64 + monocytic lineage, stud- 
ied with chromosome painting, also had the trisomy. 
DISCUSSION 
DNA FISH performed on immunophenotyped metaphase 
and interphase cells enables detection of specific chromo- 
some anomalies in different cell types. In this study, we ana- 
lyzed lineage specificity of cytogenetic alterations in three 
patients with MDS. We were able to show involvement ofthe 
erythroid lineage in all three patients, one of whom had the 
unbalanced t(1;7) and two of whom had trisomy 8. We also 
detected these aberrations inCD34 + stem cells and the mega- 
karyocytic, monocytic, and granulocytic ell lineages. We 
report he first evidence that the t(1;7) is present in erythroid 
cells as well as in the granulocytic/monocytic lineage. 
Trisomy 8 was detected in patient 4 in the erythrocytic, 
monocytic, and megakaryocytic lineages and in patient 2 in 
CD34-positive stem cells and in cells of the erythroid lin- 
eage. The CD13 + granulocytic/monocytic lineage in patient 
2 was not involved, evidence that the mutation had occurred 
in a stem cell capable of differentiating only into erythro- 
cytes. The aberration may have occurred in a stem cell capa- 
ble of differentiating into both erythrocytes and granulo- 
cytes/monocytes, but did not confer any growth advantage 
on granulocyte/monocyte lin ages. Our results are consis- 
tent with those of Kibbelaar et al. [19], who studied lineage 
involvement inMDS patients with trisomy 8and t(1;7) by com- 
bined immunophenotyping and DNA ISH. Their results also 
indicated that the chromosome aberrations are limited to my- 
eloid lineages. 
The results and our unpublished ata on cell lineage in- 
volvement in two patients with AML carrying the chromo- 
some aberration trisomy 8 indicate that trisomy 8 may not 
be restricted to any specific cell lineage. In one patient, the 
trisomy was detected in CD64 + monocytes but not in GPA- 
positive cells of the erythrocyte lineage. On the other hand, 
all myeloid lineages were affected in the second AML pa- 
tient, who also had trisomy 8. Whether the specific hromo- 
some aberration leads to a growth advantage in a given cell 
lineage may depend on the genetic history. Patient 2 had a 
low frequency of trisomy 8 cells but morphologically dys- 
plastic features in all myeloid lineages in BM, suggesting 
that trisomy 8 was not an early event in the malignant trans- 
formation. 
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To investigate whether the lymphoid cell lineages were 
affected, we performed FISH on immunophenotyped B, T,
and IA3L-cells from the patient showing t(1;7). The frequency 
of lymphoid ceils with three hybridization signals was less 
than 3%, indicating that most cells in the lymphoid line- 
ages did not contain the abnormality. A small abnormal sub- 
population of lymphoid cells may have existed; because of 
the background inFISH, the sensitivity of the technique does 
not allow detection of a cell population that consists 3% of 
the whole. 
Our results are consistent with those of Gerritsen et al. 
[20], who used FISH to investigate involvement of monosomy 
7 in myeloid and lymphoid lineages in eight MDS patients. 
The monosomy was not detected in established B- or T-cell 
lines or in separated PB lymphocytes, but was present in the 
myeloid cell compartment. A~cording to van Kamp et al. [21], 
MDS is a disorder with clonal hematopoiesis in cells of my- 
eloid origin, whereas circulating T and B lymphocytes and 
NK cells in their material were not involved. 
In our study t(1;7) was present in all myeloid lineages. We 
also showed that trisomy 8 may be present in all myeloid 
lineages, or in only a single cell lineage, which suggests that 
the mutations may occur in a stem cell with the ability to 
develop into either mature myeloid cells or in a stem cell 
committed to only one cell lineage. Our results do not ex- 
clude involvement of lymphoid cells in MDS. 
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